Most of the time, it takes decades of accumulating genetic errors for a tumor to develop. While this explains the general occurrence of cancer in adults, it leaves a gap in understanding of the cause of pediatric tumors.
Register for next month's ASPHO Webinar The Use of Yoga for Children with Cancer & Blood Disorders on Tuesday, February 28, at 3pm CT, to understand the benefits of yoga for PHO patients and to provide program development...
Attend the 2023 ASPHO Conference, May 10-13, 2023, to strengthen your pediatric hematology/oncology practice and research with the latest clinical, basic, and translational science presented by more than 100 speakers at over 40 educational...
The aim of this study was to present the diagnostic and outcome characteristics of infants with germline status of KMT2A gene (KMT2A-g) B-cell precursor acute lymphoblastic leukemia (BCP-ALL)...
Mitogen-activated protein kinase enzyme (MEK) inhibitors are used in the treatment of pediatric patients with neurofibromatosis, low grade glioma, and astrocytoma, and may demonstrate a unique side effect profile in...
Differentiated thyroid cancer (DTC) is the most common endocrine cancer during childhood, and the prognosis is usually good. The 2015 American Thyroid Association (ATA) pediatric guidelines for DTC classify...
The addition of interferon alfa to temozolomide significantly extended survival among patients with newly diagnosed high-grade gliomas, according to data published in JAMA Network Open. The temozolomide-interferon alfa combination...
Subscribe to ASPHO News Briefs | |
*Email: | |
*First Name: | |
*Last Name: | |
*Company: | |
Title: | |
Street Address: | |
City: | |
State / Province: | |
Zip / Postal Code: | |
Country: | |
Are you a member of ASPHO? | Yes No |
![]() | |
Privacy Policy |